FDA: No Monitoring Needed When Prescribing Statins

One of the most common visits in primary care may soon go away. The quarterly lipid profile and liver function check is unnecessary according to the FDA. The new guidelines have a new twist, however: There is more emphasis on the possibility of changes in cognitive function among patients taking statins.

via Press Announcements > FDA announces safety changes in labeling for some cholesterol-lowering drugs.